COMMUNIQUÉS West-GlobeNewswire

-
XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa
25/06/2019 -
Teladoc Health Names Mala Murthy as Chief Financial Officer
25/06/2019 -
Marrone Bio Innovations allowed key claims by U.S. Patent and Trademark Office for Grandevo® WDG
25/06/2019 -
Driven Deliveries Inc. Completes Acquisition of Ganjarunner, Inc. First-Year Revenue Expected to Exceed $4 Million
25/06/2019 -
Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of EDSIVO™ (celiprolol) in vEDS Patients
25/06/2019 -
Hemostemix Announces Resignation of CFO
25/06/2019 -
REPEAT - AgraFlora Organics Provides Guidance and Facility Expansion Updates at Toronto, ON Brewhouse; Increases Production Capacities by 30%
25/06/2019 -
Data Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting Highlights Potential of Progenics’ PSMA-Targeted Imaging Agent, PyL, in Detecting Prostate Cancer
25/06/2019 -
Cambrex Appoints Dottie Donnelly-Brienza as Senior Vice President and Chief Human Resources Officer
25/06/2019 -
Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors
25/06/2019 -
HealthLynked Streamlines Patient Check-in with the Release of its New Application for Healthcare Practices
25/06/2019 -
VPR Brands Provides Update on International Sales Progress
25/06/2019 -
Auxly Announces Appointment of Andrew MacMillan as VP, Commercial Business Development
25/06/2019 -
Immutep Completes Patient Enrolment of the AIPAC Phase IIb Clinical Trial in Metastatic Breast Cancer
25/06/2019 -
Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET® (avatrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease
25/06/2019 -
Predictive Technology Group Announces the Presentation of New Data Demonstrating the Genetic Basis of Endometriosis at ESHRE
25/06/2019 -
Progressive Care Inc. Announces Steady Sales Growth in May
25/06/2019 -
Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613® (devimistat) in Japan and Other Asian Countries
25/06/2019 -
Samuel E. Navarro Appointed to BioSig Board of Directors
25/06/2019
Pages